Myeloperoxidase, Subclinical Atherosclerosis, and Cardiovascular Disease Events

JACC: Cardiovascular Imaging

Volumn 2, Issue 9, 2009, Pages 1093-1099

  Wong, Nathan D ^a   Gransar, Heidi ^b   Narula, Jagat ^a   Shaw, Leslee ^c   Moon, Johanna H ^b   Miranda Peats, Romalisa ^b   Rozanski, Alan ^d   Hayes, Sean W ^b   Thomson, Louise E J ^b,e   Friedman, John D ^b,e   Berman, Daniel S ^b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Division of Nuclear Medicine   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

biomarkers; cardiovascular disease; computed tomography; prevention; risk factors

Indexed keywords

CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; IMMUNOASSAY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SMOKING; SYSTOLIC BLOOD PRESSURE;

AGED; BIOLOGICAL MARKERS; CALCINOSIS; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; IMMUNOASSAY; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PEROXIDASE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; UP-REGULATION;

EID: 70249144887     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.05.012     Document Type: Article

References (18)

1. Nicholls S.J., and Hazen S.L. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 1102-1111
2. Baldus S., Heeschen C., Meinertz T., et al., CAPTURE Investigators. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108 (2003) 1440-1445
3. Mocatta T.J., Pilbrow A.P., Cameron V.A., et al. Plasma levels of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 49 (2007) 1993-2000
4. Meuwese M.C., Stroes E.S., Hazen S.L., et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 50 (2007) 159-165
5. Greenland P., Bonow R.O., Brundage B.H., et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 49 (2007) 378-402
6. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte Jr. M., and Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990) 827-832
7. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
8. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating curves: a nonparametric approach. Biometrics 44 (1988) 837-845
9. Brennan M.L., Penn M.S., Van Lente F., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349 (2003) 1595-1604
10. Cavusoglu E., Ruwende C., Eng C., et al. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. Am J Cardiol 99 (2007) 1364-1368
11. Stefanescu A., Braun S., Ndrepepa G., et al. Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease. Am Heart J 155 (2008) 356-360
12. Khan S.Q., Kelly D., Quinn P., et al. Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction. Heart 93 (2007) 826-831
13. Vita J.A., Brennan M.L., Gokce N., et al. Serum myeloperoxidase levels independent predict endothelial dysfunction in humans. Circulation 11 (2004) 1134-1139
14. Exner M., Minar E., Mlekusch W., et al. Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol. J Am Coll Cardiol 47 (2006) 2212-2218
15. Meuwese M.C., Trip M.D., van Wissen S., van Miert J.N., Kastelein J.J., and Stroes E.S. Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia. Atherosclerosis 197 (2008) 916-921
16. Greenland P., LaBree L., Azen S.P., Doherty T.M., and Detrano R.C. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291 (2004) 210-215
17. Shaw L.J., Raggi P., Schisterman E., Berman D.S., and Callister T.Q. Prognostic value of cardiac risk factors and coronary artery calcium for all-cause mortality. Radiology 228 (2003) 826-833
18. Detrano R., Guerci A.D., Carr J.J., et al. Coronary calcium as a predictor of near-term coronary heart disease events in major American ethnic groups: the Multiethnic Study of Atherosclerosis (MESA). N Engl J Med 358 (2008) 1336-1345